Galectin Therapeutics Inc (NASDAQ:GALT)

2.64
Delayed Data
As of 12:09pm ET
 +0.02 / +0.76%
Today’s Change
2.52
Today|||52-Week Range
16.55
-23.92%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash--9.4M10.5M29.1M
 
 
 
 
Short Term Investment Cash506.0K3.0M1.1M18.6M
 
 
 
 
 
Cash & Short Term Investments6.4M9.4M10.5M29.1M
 
 
 
 
 
 
ReceivablesReceivables0.000.000.000.00--
 
InventoriesInventories0.000.00------
 
Current AssetsPrepaid Expenses--153.0K----
 
 
Other Current Assets104.0K0.00198.0K527.0K
 
 
 
 
Current Assets6.5M9.5M10.7M29.7M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross321.0K74.0K74.0K74.0K
 
 
 
 
 
Depreciation-315.0K-66.0K-71.0K-73.0K
 
 
 
 
 
Intangible Assets36.0K30.0K23.0K15.0K
 
 
 
 
 
Other Assets36.0K30.0K23.0K15.0K
 
 
 
 
 
Total Assets6.6M9.6M10.7M29.7M
 
 
 
 
 
 
LiabilitiesAccounts Payable384.0K397.0K762.0K0.00
 
 
 
 
Accrued Expenses1.2M1.1M1.1M125.0K
 
 
 
 
 
Other Current Liabilities1.4M1.1M1.1M1.0M
 
 
 
 
 
Other Liabilities2.2M1.6M2.5M1.7M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities0.006.0K0.000.00
 
 
Total Liabilities2.2M1.6M2.5M1.7M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock7.2M7.4M7.3M7.3M
 
 
 
 
 
Common Equity-2.8M533.0K894.0K20.6M
 
 
 
 
 
Total Shareholder Equity4.4M7.9M8.2M28.0M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding12.9M16.1M18.4M22.3M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account